vimarsana.com
Home
Live Updates
Zealand Pharma A/S : Interim Report for Q1 2023 : vimarsana.com
Zealand Pharma A/S : Interim Report for Q1 2023
Company announcement
No. 20 / 2023
Zealand Pharma Announces Financial Results for the First Quarter of 2023.
... | May 11, 2023
Related Keywords
Denmark ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Boston ,
Massachusetts ,
United States ,
Ukraine ,
France ,
Paris ,
France General ,
United Kingdom ,
Copenhagen ,
Køavn ,
American ,
Adam Steensberg ,
Zealand Pharma ,
David Kendall ,
Novo Nordisk ,
Henriette Wennicke ,
Anna Krassowska ,
Boehringer Ingelheim ,
Danske Bank ,
European Commission ,
European Medicines Agency ,
American Diabetes Association ,
Investor Relations Corporate Communications ,
Pharma Announces Financial Results ,
First Quarter ,
Chief Executive Officer ,
Scientific Sessions ,
Oberland Capital ,
Chief Financial Officer ,
Chief Medical Officer ,
Private Securities Litigation Reform Act ,
Upcoming Events ,
Financial Guidance ,
Investor Relations ,
Corporate Communications ,
Practice Conference ,
Digestive Diseases Week ,
Lancet Gastroenterology ,
Zealand Pharmaas Stock Exchange ,
News ,
Information ,
Press Release ,
Company ,
0 ,
Zealand ,
Dharma ,
Nnounces ,
Financial ,
Results ,
Or ,
The ,
First ,
Quarter ,
F Zeal Dk0060257814 ,
vimarsana.com © 2020. All Rights Reserved.